CN Patent

CN111559997A — 一种达格列净新晶型及其制备方法

Assigned to Luoxin Biotechnology Shanghai Co ltd · Expires 2020-08-21 · 6y expired

What this patent protects

本发明涉及一种达格列净新晶型及其制备方法。具体而言，本发明的达格列净新晶型的使用Cu‑Kα测量的X射线粉末衍射图谱在以下2θ角处具有特征衍射峰：5.347±0.2°，7.623±0.2°，10.484±0.2°，15.308±0.2°，15.850±0.2°。本发明的晶型的含水量低、纯度高、产品稳定性高、晶癖好。

USPTO Abstract

本发明涉及一种达格列净新晶型及其制备方法。具体而言，本发明的达格列净新晶型的使用Cu‑Kα测量的X射线粉末衍射图谱在以下2θ角处具有特征衍射峰：5.347±0.2°，7.623±0.2°，10.484±0.2°，15.308±0.2°，15.850±0.2°。本发明的晶型的含水量低、纯度高、产品稳定性高、晶癖好。

Drugs covered by this patent

Patent Metadata

Patent number
CN111559997A
Jurisdiction
CN
Classification
—
Expires
2020-08-21
Drug substance claim
No
Drug product claim
No
Assignee
Luoxin Biotechnology Shanghai Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.